Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

2.245 +0.025 (+1.13%)
Streaming Delayed Price Updated: 10:47 AM EDT, Aug 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Maravai LifeSciences Reports Fourth Quarter and Full Year 2022 Financial Results
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
2 Healthcare Companies That Could Be Acquired Within 5 Years
These stocks are also cheap buys that are down more than 60% from their highs. 
Via The Motley Fool
Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover
Danaher is reportedly looking to add to its wheelhouse to compete with Thermo. 
Via Investor's Business Daily
Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
5 Value Stocks In The Healthcare Sector
 
Via Benzinga
Where Maravai LifeSciences Stands With Analysts
 
Via Benzinga
6 Analysts Have This to Say About Maravai LifeSciences
 
Via Benzinga
Where Maravai LifeSciences Stands With Analysts
Analysts have provided the following ratings for Maravai LifeSciences (NASDAQ:MRVI) within the last quarter: 
Via Benzinga
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022. 
Via Benzinga
Earnings Outlook For Maravai LifeSciences
 
Via Benzinga
Analyst Ratings for Maravai LifeSciences
Analysts have provided the following ratings for Maravai LifeSciences (NASDAQ:MRVI) within the last quarter: 
Via Benzinga
3 Great Growth Stocks Down 20% or More to Buy Now
These beaten-down stocks could be poised for major rebounds. 
Via The Motley Fool
3 Biopharma Stocks That Could Help Make You a Fortune
All three are protected by sales of in-demand products, with more on the way. 
Via The Motley Fool
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's trading, 138 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  Thursday saw 177 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 200 companies hit new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
 
Via Benzinga
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
2 Biotech Stocks You Can Buy and Hold for the Next Decade
These two companies are facing short-term issues that are likely to give way to long-term success. 
Via The Motley Fool
Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
New Kit Predicts Retroviral Particle Clearance in Biopharmaceutical Manufacturing
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
What 6 Analyst Ratings Have To Say About Maravai LifeSciences
Within the last quarter, Maravai LifeSciences (NASDAQ:MRVI) has observed the following analyst ratings: 
Via Benzinga
Maravai LifeSciences Announces November and December 2022 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off the day with a look at the latest news behind the biggest pre-market stock movers for Thursday morning! 
Via InvestorPlace
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2022 Earnings Call Transcript
MRVI earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Maravai LifeSciences Reports Third Quarter 2022 Financial Results
Updates Revenue, Adjusted EBITDA and Adjusted EPS Guidance for 2022 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
This Fallen Growth Stock Is Still a Wall Street Favorite: Here's Why
It's positioned to benefit from the emergence of a new, long-term trend in biopharma. 
Via The Motley Fool
Abbott Laboratories, M&T Bank And Some Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Maravai LifeSciences Temporarily Reinstates Carl Hull as CEO Amidst Pending Noncompetition Litigation
Maravai LifeSciences and Recently-Appointed CEO Trey Martin Vigorously Defending Against Suit 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.